Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer a southwest oncology group study (Q72722085)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 March 1984
edit
Language Label Description Also known as
English
Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer a southwest oncology group study
scientific article published on 01 March 1984

    Statements

    title
    Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer. A Southwest Oncology Group study (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    6198064
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6198064%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    28 October 2019
    Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer a southwest oncology group study (English)
    1 reference
    stated in
    Crossref
    DOI
    10.1002/1097-0142(19840301)53:5<1029::AID-CNCR2820530503>3.0.CO;2-Z
    reference URL
    https://api.crossref.org/works/10.1002/1097-0142(19840301)53:5%3C1029::AID-CNCR2820530503%3E3.0.CO;2-Z
    retrieved
    26 August 2023
    author name string
    cites work

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q72722085&oldid=2207630224"